Effect of oestrogen and progesterone on fasting serum cholesterol and triglyceride levels in post-menopausal women

Non-randomised trial OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-10-05 ⓘ

This study of 240 post-menopausal women found that various oestrogen and progestational agent treatments for climacteric symptoms did not adversely affect fasting serum cholesterol or triglyceride levels.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A study of 240 post-menopausal women receiving Dixarit (clonidine hydrochloride), Premarin (conjugated equine oestrogens), Harmogen (piperazine oestrone sulphate) and Progynova (oestradiol valerate) in two different dosages alone and in combination with progestational agents such as norethisterone acetate, dydrogesterone, and norgestrel for climacteric symptoms showed that there was no adverse effect on serum lipid levels. There was no significant change in the serum cholesterol and triglyceride levels during treatment with oestrogen replacement therapy.

My notes (saved in your browser only)

MeSH descriptors

Cholesterol Estradiol Congeners Menopause Progesterone Congeners Triglycerides Adult Aged Cholesterol Clonidine Clonidine Dydrogesterone Dydrogesterone Estradiol Estradiol Estradiol Estradiol Congeners Estrogens, Conjugated (USP) Estrogens, Conjugated (USP) Estrone Estrone

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (22)

Source provenance

openalex
last seen: 2026-05-11T04:45:27.910651+00:00
pubmed
last seen: 2026-10-08T21:58:02.984372+00:00
unpaywall
last seen: 2026-11-01T06:18:20.579057+00:00
License: CC0 · commercial use OK